Press Release from NCI: NCI study advances personalized immunotherapy for metastatic breast cancer National Cancer Institute sent this bulletin at 02/01/2022 04:10 PM EST The latest press release from the National Cancer Institute Having trouble viewing this email? View it as a Web page. You are subscribed to Press Releases from the National Cancer Institute. New press releases are listed below. NCI study advances personalized immunotherapy for metastatic breast cancer 02/01/2022 NCI researchers have shown that an experimental form of immunotherapy that uses an individual’s own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer who have exhausted all other treatment options.
